Omalizumab
Showing 1 - 25 of 256
Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab
Not yet recruiting
- Chronic Spontaneous Urticaria
- Chronic Urticaria, Idiopathic
- omalizumab 300 mg every four weeks
- omalizumab 300 mg every six weeks
-
Copenhagen, Copenhagen N, DenmarkDepartment of Dermatology, Bispebjerg Hospital
Jun 21, 2023
Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)
Not yet recruiting
- Chronic Spontaneous Urticaria
- Remibrutinib
- +3 more
- (no location specified)
Sep 20, 2023
Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps Trial in Baltimore (Omalizumab)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Nasal Polyps
- Omalizumab
-
Baltimore, Maryland
- +1 more
Jan 18, 2023
Asthma in Children, Atopy, Viral Upper Respiratory Infection Trial in Washington (Omalizumab, Placebo)
Recruiting
- Asthma in Children
- +2 more
- Omalizumab
- Placebo
-
Washington, District of ColumbiaChildren's National Hospital
Aug 26, 2022
Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)
Active, not recruiting
- Covid19
- Omalizumab
- Placebo
-
Niagara, Ontario, Canada
- +2 more
Nov 14, 2022
Food Allergy Trial in Odense C (Omalizumab, Placebo)
Recruiting
- Food Allergy
- Omalizumab
- Placebo
-
Odense C, Funen, DenmarkOdense Research Center for Anaphylaxis, Allergy Center, Odense U
Sep 20, 2022
Omalizumab in Children With Allergic Asthma.
Completed
- Allergic Asthma
- Omalizumab
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
Recruiting
- Spontaneous Urticaria, Chronic
-
Lille, FranceHop Claude Huriez Chu Lille
Jan 25, 2023
Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)
Not yet recruiting
- Nasal Polyps
- Omalizumab
- SNOT22 score
-
Shiraz, Fars, Iran, Islamic Republic ofImam Reza Allergy and Immunology clinic, Shiraz University of Me
May 31, 2022
Xolair® in Pediatric Chronic Spontaneous Urticaria in China
Not yet recruiting
- Chronic Spontaneous Urticaria
- Xolair
- (no location specified)
Sep 19, 2023
Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab
Completed
- Allergic Asthma
- Uncontrolled Moderate to Severe
- Omalizumab (CinnaGen)
- Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
-
Ahvaz, Iran, Islamic Republic of
- +21 more
Apr 3, 2023
Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)
Not yet recruiting
- Chronic Idiopathic Urticaria
- Omalizumab Injection
- Xolair Prefilled Syringe
- (no location specified)
Mar 7, 2023
Asthma, Allergic Trial (omalizumab)
Not yet recruiting
- Asthma, Allergic
- omalizumab
- (no location specified)
Aug 30, 2023
XOLAIR Outcomes in Pediatric Allergic Asthma United States
Completed
- Asthma
- Omalizumab
-
East Hanover, New JerseyNovartis Investigational Site
Dec 15, 2021
Food IgE-mediated Allergy, Immunotherapy, Omalizumab Trial in Toronto, Montréal, Sherbrooke (Omalizumab 16mg/kg, Omalizumab
Recruiting
- Food IgE-mediated Allergy
- +3 more
- Omalizumab 16mg/kg
- +3 more
-
Toronto, Ontario, Canada
- +2 more
Jan 31, 2022
Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)
Completed
- Food Allergy
- Drug: Chinese Herbal Medication
- +2 more
- (no location specified)
Oct 24, 2023
Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)
Completed
- Healthy Volunteers
- CMAB007
- Xolair
-
Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 8, 2023
Fluctuation Analyses of Asthma Patients With Biologics Use
Not yet recruiting
- Asthma
- Biological Drug
- (no location specified)
Sep 7, 2023
Asthma, Infertility, Female Trial in Copenhagen (Omalizumab Injection, NaCl)
Recruiting
- Asthma
- Infertility, Female
- Omalizumab Injection
- NaCl
-
Copenhagen, DenmarkCharlotte Suppli Ulrik
Dec 16, 2021
Omalizumab on Corticosteroid Use, Emergency Room Visits and
Withdrawn
- Asthma
- (no location specified)
Nov 23, 2021
Asthma Trial in Paris (Attempt to withdrawal OMA treatment, Continuation of OMA treatment)
Recruiting
- Asthma
- Attempt to withdrawal OMA treatment
- Continuation of OMA treatment
-
Paris, Île De France, FranceHöpital Bichat-Claude Bernard
Feb 9, 2022
Asthma Trial in Shanghai (Omalizumab)
Completed
- Asthma
- Omalizumab
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 8, 2021
Chronic Urticaria, Idiopathic Trial in Aurora (Omalizumab)
Recruiting
- Chronic Urticaria, Idiopathic
- Omalizumab
-
Aurora, ColoradoUniversity of Colorado Anschutz
Mar 23, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial in Ghent (Mepolizumab)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Mepolizumab
-
Ghent, BelgiumGhent University Hospital
Jul 6, 2023